| Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration JWD Tobin, C Keane, J Gunawardana, P Mollee, S Birch, T Hoang, J Lee, ... Journal of Clinical Oncology 37 (34), 3300, 2019 | 112 | 2019 |
| EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity MK Gandhi, T Hoang, SC Law, S Brosda, K O’Rourke, JWD Tobin, F Vari, ... Blood, The Journal of the American Society of Hematology 137 (11), 1468-1477, 2021 | 73 | 2021 |
| Successful treatment of Epstein–Barr virus–associated primary central nervous system lymphoma due to post-transplantation lymphoproliferative disorder, with ibrutinib and third … SC Law, T Hoang, K O’Rourke, JWD Tobin, J Gunawardana, D Loo-Oey, ... American Journal of Transplantation 21 (10), 3465-3471, 2021 | 15 | 2021 |
| The tumor microenvironment is independently prognostic of conventional and clinicogenetic risk models in follicular lymphoma JWD Tobin, C Keane, P Mollee, S Birch, C Gould, J Gunawardana, ... Blood 130, 728, 2017 | 3 | 2017 |
| The impact of EBV upon the tumor microenvironment and mutational profile of primary CNS lymphoma in PTLD MK Gandhi, C Keane, JWD Tobin, D Talaulikar, S Jain, F Vari, L Kruze, ... Blood 130, 2731, 2017 | 2 | 2017 |
| EBV+ CNS LYMPHOMAS HAVE A DISTINCTIVE TUMOR MICROENVIRONMENT AND GENETIC PROFILE, WHICH IS AMENABLE TO COMBINATION 3RD PARTY EBV‐SPECIFIC CTL AND IBRUTINIB THERAPY MK Gandhi, T Hoang, JW Tobin, SC Law, D Talaulikar, S Jain, F Vari, ... Hematological Oncology 37, 130-132, 2019 | 1 | 2019 |
| The Tumour Microenvironment as an Independent Prognostic Biomarker in Follicular Lymphoma J Tobin, C Keane, P Mollee, S Birch, C Gould, J Gunawardana, T Hoang, ... Internal Medicine Journal 48 (s5), 5-6, 2018 | | 2018 |
